Maureen Dubreuil, MD, MSc.
Assistant Professor, Medicine
Biography
Dr. Dubreuil is a rheumatologist in Boston, specializing in Spondyloarthritis. She works within the Rheumatology section at Chobanian and Avedisian School of Medicine, where her research focuses on comorbidities and pharmacoepidemiology of spondyloarthritis. In 2013, she was awarded the Arthritis Foundation Clinical to Research Transition Award and 2016, she began work on a K23-funded project to study patient preferences, and the cost-effectiveness of treatment modalities for spondyloarthritis, to inform both clinical care and policy decisions. She serves as Education Chair and Board Member for the Spondyloarthritis Research and Treatment Network (SPARTAN), is a Medical Advisor for the Spondylitis Association of America, and is a member of the Assessment of Spondyloarthritis International Society (ASAS). She is a site investigator for the international CLASSIC study and the PULSAR spondyloarthritis registry.
Other Positions
- Member, Arthritis & Autoimmune Diseases Research Center, Boston University
- VA Boston Healthcare System
Websites
- BU Profile
- Dr. Dubreuil's publications on PubMed
- Rheumatology Faculty at BU Medical Center
- BU Rheumatology
- Boston Medical Center Provider Profile
- VA Boston Healthcare System Rheumatology Clinic
- American College of Rheumatology Abstracts by Dr. Dubreuil
- ACR On Air Podcast Episode: Treating Spondyloarthritis
- BU Rheumatology Fellowship Program Video
- An interview on WebMD about Ankylosing Spondylitis
- Dr. Dubreuil's profile on LinkedIn
- SPARTAN (Spondyloarthritis Research and Treatment Network)
- Spondylitis Association of America
Education
- University of Connecticut School of Medicine, MD
- Boston University School of Public Health, MSc
- Rochester Institute of Technology, BS
Publications
- Published on 9/7/2023
George N, Liew JW, Dubreuil M. The role of upadacitinib for the treatment of axial spondyloarthritis. Immunotherapy. 2023 Oct; 15(15):1227-1237. PMID: 37675498.
Read at: PubMed - Published on 6/12/2023
Merjanah S, Liew JW, Bihn J, Fillmore NR, Brophy MT, Do NV, Dubreuil M. Trends in Fracture Rates Over Two Decades Among Veterans With Ankylosing Spondylitis. Arthritis Care Res (Hoboken). 2023 Jun 12. PMID: 37308459.
Read at: PubMed - Published on 4/10/2023
Beaudette-Zlatanova B, Lew RA, Otis JD, Branch-Elliman W, Bacorro E, Dubreuil M, Eyvazzadeh C, Kaur M, Lazzari AA, Libbey C, Monach PA. Pilot Study of Low-dose Naltrexone for the Treatment of Chronic Pain Due to Arthritis: A Randomized, Double-blind, Placebo-controlled, Crossover Clinical Trial. Clin Ther. 2023 May; 45(5):468-477. PMID: 37045708.
Read at: PubMed - Published on 2/23/2023
Kumar D, Neogi T, Peloquin C, Marinko L, Camarinos J, Aoyagi K, Felson DT, Dubreuil M. Delayed timing of physical therapy initiation increases the risk of future opioid use in individuals with knee osteoarthritis: a real-world cohort study. Br J Sports Med. 2023 Aug; 57(15):958-964. PMID: 36822841.
Read at: PubMed - Published on 2/14/2023
Machado PM, Schäfer M, Mahil SK, Liew J, Gossec L, Dand N, Pfeil A, Strangfeld A, Regierer AC, Fautrel B, Alonso CG, Saad CGS, Griffiths CEM, Lomater C, Miceli-Richard C, Wendling D, Alpizar Rodriguez D, Wiek D, Mateus EF, Sirotich E, Soriano ER, Ribeiro FM, Omura F, Rajão Martins F, Santos H, Dau J, Barker JN, Hausmann J, Hyrich KL, Gensler L, Silva L, Jacobsohn L, Carmona L, Pinheiro MM, Zelaya MD, Severina MLÁ, Yates M, Dubreuil M, Gore-Massy M, Romeo N, Haroon N, Sufka P, Grainger R, Hasseli R, Lawson-Tovey S, Bhana S, Pham T, Olofsson T, Bautista-Molano W, Wallace ZS, Yiu ZZN, Yazdany J, Robinson PC, Smith CH. Characteristics associated with poor COVID-19 outcomes in people with psoriasis, psoriatic arthritis and axial spondyloarthritis: data from the COVID-19 PsoProtect and Global Rheumatology Alliance physician-reported registries. Ann Rheum Dis. 2023 May; 82(5):698-709. PMID: 36787993.
Read at: PubMed - Published on 1/10/2023
Kwan YH, Phang JK, Woon TH, Liew JW, Dubreuil M, Proft F, Ramiro S, Molto A, Navarro-Compán V, de Hooge M, Meghnathi B, Ziade N, Zhao SS, Llop M, Baraliakos X, Fong W. Social Media Use Among Members of the Assessment of Spondyloarthritis International Society: Results of a Web-Based Survey. J Med Internet Res. 2023 Jan 10; 25:e39155. PMID: 36626201.
Read at: PubMed - Published on 7/30/2022
Liew JW, Dubreuil M. Upadacitinib for the treatment of active non-radiographic axial spondyloarthritis. Lancet. 2022 Jul 30; 400(10349):340-341. PMID: 35908562.
Read at: PubMed - Published on 12/13/2021
Yau MS, Dubreuil M, Li S, Inamdar V, Peloquin C, Felson DT. Validation of knee osteoarthritis case identification algorithms in a large electronic health record database. Osteoarthr Cartil Open. 2022 Mar; 4(1). PMID: 35601472.
Read at: PubMed - Published on 12/1/2021
Liew JW, Jafarzadeh SR, Dubreuil M, Heckbert SR, Mooney SJ, Brown MA, Ishimori ML, Reveille JD, Ward MM, Weisman MH, Gensler LS. The Association of Tumor Necrosis Factor Inhibitor Use With Incident Hypertension in Ankylosing Spondylitis: Data From the PSOAS Cohort. J Rheumatol. 2022 03; 49(3):274-280. PMID: 34853088.
Read at: PubMed - Published on 12/1/2021
Stovall R, Peloquin C, Felson D, Neogi T, Dubreuil M. Relation of NSAIDs, DMARDs, and TNF Inhibitors for Ankylosing Spondylitis and Psoriatic Arthritis to Risk of Total Hip and Knee Arthroplasty. J Rheumatol. 2021 Dec; 48(12):1892. PMID: 34853165.
Read at: PubMed
View 48 more publications: View full profile at BUMC